Idaho’s full Senate has voted 22 to 12 to approve Senate Bill 1146 a proposal to legalize the possession and use of low-THC cannabis extracts for the treatment of epilepsy. The Senate also voted to approve the use of Epidiolex, a cannabis-based medicine from the makers of Sativex. The vote on the latter proposal, Senate Bill 1156, was unanimous.
Senate Bill 1146 would allow those with epilepsy who receive a recommendation from a physician to possess and use cannabis extracts – such as tinctures and oils – that have low amounts of THC (tetrahydrocannabinol), and high amounts of CBD (cannabidiol). Unfortunately no legal method of obtaining the medicine was established.